Z6尊龙
Other Affiliated Sites
Techdow Pharma China
Techdow Pharma UK
Techdow Pharma Poland
Techdow Pharma Italy
Techdow Pharma Spain
Techdow Pharma Germany
Techdow Pharma US
Cytovance Biologics
SPL
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2023.03.30
Z6尊龙:关于续聘会计师事务所的通告
2023.03.30
Z6尊龙:自力董事候选人关于加入最近一次自力董事培训的书面允许
2023.03.30
Z6尊龙:公司章程(2023年3月)
2023.03.30
Z6尊龙:自力董事年度述职报告
2023.03.30
Z6尊龙:2022年年度报告摘要
2023.03.30
Z6尊龙:关于使用自有资金购置理工业品及举行现金治理的通告
2023.03.30
Z6尊龙:自力董事关于第五届董事会第二十五次聚会相关事项之事前认可意见
2023.03.30
Z6尊龙:自力董事提名人声明(易铭)
2023.03.30
Z6尊龙:自力董事候选人声明(易铭)
2023.03.30
Z6尊龙:关于开展以套期保值为目的的外汇衍生品生意的可行性剖析报告
第一页
上一页
6
7
8
9
10
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright ? 2024 Hepalink Group. All Rights Reserved.
【网站地图】
【sitemap】